Alumis Inc. - Common Stock (NQ: ALMS )

10.35 +0.06 (+0.58%)

Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist

Price and Volume

Volume	50,107
Open	10.46
Bid (Size)	4.900 (1)
Ask (Size)	11.99 (12)
Prev. Close	10.29
Today's Range	10.26 - 10.47
52wk Range	9.540 - 13.53
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock'

October 09, 2024

Target (TGT) stock recommended by Jim Cramer at current price with plans to buy more. Merck (MRK) and Unity Software (U) also discussed.

Via Benzinga

Alumis to Participate in Upcoming September Investor Conferences

September 03, 2024

From Alumis Inc.

Via GlobeNewswire

Performance

YTD	-22.18%	-22.18%
1 Month	-8.08%	-8.08%
3 Month	-8.33%	-8.33%
6 Month	-22.18%	-22.18%
1 Year	-22.18%	-22.18%

More News

ALMS Stock Earnings: Alumis Reported Results for Q2 2024

August 15, 2024

Via InvestorPlace

Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements

August 13, 2024

From Alumis Inc.

Via GlobeNewswire

Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis

July 29, 2024

From Alumis Inc.

Via GlobeNewswire

Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation

July 24, 2024

Via Benzinga

Ardent Health Slips After Downsized IPO

July 21, 2024

Via Talk Markets

Immune Disease-Focused Alumis Raises $250M In Downsized Initial Public Offering

June 28, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.